SCOPUS 정보 검색 플랫폼

Volumn 87, Issue 3, 2002, Pages 268-276

Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy

(11) Glaspy, J A a Jadeja, J S b Justice, G c Kessler, J d Richards, D e Schwartzberg, L f Tchekmedyian, N S g Armstrong, S h O'Byrne, J h Rossi, G h Colowick, A B h

a UNIVERSITY OF CALIFORNIA (United States)

b Hematology Oncology Associates of Jacksonville (United States)

c Pacific Coast Hematology/Oncology Medical Group (United States)

d Virginia Oncology Associates (United States)

e Tyler Cancer Center (United States)

f West Clinic (United States)

g Pacific Shores Medical Group (United States)

h AMGEN INC (United States)

Author keywords

Anaemia; Chronic disease; Erythropoietin; Neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FATIGUE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS;

EID: 18544383775 PISSN: 00070920 EISSN: None Source Type: Journal
DOI: 10.1038/sj.bjc.6600465 Document Type: Article

Times cited : (156)

References (17)

1
- 0037075272
- Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin
- (2002) N Engl J Med , vol.346 , pp. 469-475
- Casadevall, N.¹ Nataf, J.² Viron, B.³ Kolta, A.⁴ Kiladjian, J.-J.⁵ Martin-Dupont, P.⁶ Michaud, P.⁷ Papo, T.⁸ Ugo, V.⁹ Teyssandier, I.¹⁰ Varet, B.¹¹ Mayeux, P.¹²

2
- 0028295942
- Recombinant human erythropoietin treatment in cisplatin-associated anemia: A randomized double-blind trial with placebo
- (1994) J Clin Oncol , vol.12 , pp. 1058-1062
- Cascinu, S.¹ Fedeli, A.² Del Ferro, E.³ Luzi Fedeli, S.⁴ Catalano, G.⁵

3
- 0031785826
- Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
- Procrit Study Group
- (1998) J Clin Oncol , vol.16 , pp. 3412-3425
- Demetri, G.D.¹ Kris, M.² Wade, J.³ Degos, L.⁴ Cella, D.⁵

4
- 0034997401
- Development and characterization of novel erythropoiesis stimulating protein (NESP)
- (2001) Br J Cancer , vol.84 , pp. 3-10
- Egrie, J.C.¹ Browne, J.K.²

5
- 0002418073
- Novel erythropoiesis stimulating protein (NESP) has a longer serum half-life and greater in vivo biological activity than recombinant human erythropoietin (rHuEPO)
- abstract
- (1997) Blood , vol.90 , pp. 56a-57a
- Egrie, J.C.¹ Dwyer, E.² Lykos, M.³ Hitz, A.⁴ Browne, J.K.⁵

6
- 0035366382
- Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing
- (2001) J Clin Oncol , vol.19 , pp. 2875-2882
- Gabrilove, J.L.¹ Cleeland, C.S.² Livingston, R.B.³ Sarokhan, B.⁴ Winer, E.⁵ Einhorn, L.H.⁶

7
- 0031044609
- Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
- Procrit Study Group
- (1997) J Clin Oncol , vol.15 , pp. 1218-1234
- Glaspy, J.¹ Bukowski, R.² Steinberg, D.³ Taylor, C.⁴ Tchekmedyian, S.⁵ Vadhan-Raj, S.⁶

8
- 0035021354
- A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy
- (2001) Br J Cancer , vol.84 , pp. 17-23
- Glaspy, J.¹ Jadeja, J.S.² Justice, G.³ Kessler, J.⁴ Richards, D.⁵ Schwartzberg, L.⁶ Rigas, J.⁷ Kuter, D.⁸ Harmon, D.⁹ Prow, D.¹⁰ Demetri, G.¹¹ Gordon, D.¹² Arseneau, J.¹³ Saven, A.¹⁴ Hynes, H.¹⁵ Boccia, R.¹⁶ O'Byrne, J.¹⁷ Colowick, A.B.¹⁸

9
- 0034997274
- Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: Preliminary report
- (2001) Br J Cancer , vol.84 , pp. 11-16
- Heatherington, A.C.¹ Schuller, J.² Mercer, A.J.³

10
- 0028352377
- Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: Results of double-blind and open-label follow-up studies
- (1994) Semin Oncol , vol.21 , pp. 21-28
- Henry, D.H.¹ Abels, R.I.²

11
- 0000367668
- The ARANESP 980291 study group, randomized, double-blind, placebo controlled phase I/II dose finding study of ARANESP™ administered once every three weeks in solid tumor patients
- abstract
- (2000) Blood , vol.96 , pp. 294a-295a
- Kotasek, D.¹ Berg, R.² Poulsen, E.³ Colowick, A.⁴

12
- 0035367087
- Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
- (2001) J Clin Oncol , vol.19 , pp. 2865-2874
- Littlewood, T.J.¹ Bajetta, E.² Nortier, J.W.R.³ Vercammen, E.⁴ Rapoport, B.⁵

13
- 0034959059
- An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP)
- (2001) Nephrol Dialysis Transplant , vol.16 , pp. 14-21
- Macdougall, I.C.¹

14
- 0032737391
- Pharmacokinetics of novel erythropoiesis stimulating protein compared with Epoetin alfa in dialysis patients
- (1999) J Am Soc Nephrol , vol.10 , pp. 2392-2395
- Macdougall, I.C.¹ Gray, S.² Elston, O.³ Breen, C.⁴ Jenkins, B.⁵ Egrie, J.⁶

15
- 0025315364
- Decreased erythropoietin response in patients with anemia of cancer
- (1990) N Engl J Med , vol.332 , pp. 1689-1692
- Miller, C.B.¹ Jones, R.J.² Piantodosi, S.³ Abeloff, M.D.⁴ Spivak, J.L.⁵

16
- 0035000303
- Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer
- (2001) Br J Cancer , vol.84 , pp. 24-30
- Smith, R.E.¹ Jaiyesimi, I.A.² Meza, L.A.³ Tchekmedyian, N.S.⁴ Chan, D.⁵ Griffith, H.⁶ Brosman, S.⁷ Bukowski, R.⁸ Murdock, M.⁹ Rarick, M.¹⁰ Saven, A.¹¹ Colowick, A.B.¹² Fleishman, A.¹³ Gayko, U.¹⁴ Glaspy, J.¹⁵

17
- 0030877720
- Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of tripart assessment survey
- The Fatigue Coalition
- (1997) Semin Hematol , vol.34 , pp. 4-12
- Vogelzang, N.J.¹ Brietbart, W.² Cella, D.³ Curt, G.A.⁴ Groopman, J.E.⁵ Horning, S.J.⁶ Itri, L.M.⁷ Johnson, D.H.⁸ Scher, S.L.⁹ Portenoy, R.K.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.